Moderna
MRNA
#1217
Rank
C$22.03 B
Marketcap
$57.25
Share price
-3.95%
Change (1 day)
-56.80%
Change (1 year)
Moderna, Inc. is an American biotechnology company focused on the discovery and development of messenger RNA-based drugs.

Moderna (MRNA) - Total assets

Total assets on the balance sheet as of September 2024 : C$22.95 Billion

According to Moderna 's latest financial reports the company's total assets are C$22.95 Billion. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Moderna - Total assets on balance sheet (from 2017 to 2024)

Total assets by year

Year Total assets Change
2023-12-31C$24.43 B-30.35%
2022-12-31C$35.08 B11.61%
2021-12-31C$31.43 B236.06%
2020-12-31C$9.35 B350.66%
2019-12-31C$2.07 B-22.33%
2018-12-31C$2.67 B96.03%
2017-12-31C$1.36 B-28.41%
2016-12-31C$1.90 B

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
C$0.13 B-99.41%๐Ÿ‡บ๐Ÿ‡ธ USA
C$170.70 B 643.73%๐Ÿ‡บ๐Ÿ‡ธ USA
C$10.78 M-99.95%๐Ÿ‡บ๐Ÿ‡ธ USA
C$6.10 B-73.39%๐Ÿ‡บ๐Ÿ‡ธ USA
C$150.35 B 555.09%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
C$1.65 B-92.79%๐Ÿ‡บ๐Ÿ‡ธ USA
C$258.94 B 1,028.18%๐Ÿ‡บ๐Ÿ‡ธ USA
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA